Home
Our Company
Products and Solutions
Investors
About DSS
History of Innovation
Our Technologies
Partners/Associations
Our Leadership
Certified Printer Program
Brand Protection Solutions
Secure Print Solutions
Packaging Solutions
Plastics Solutions
Enterprise Solutions
Digital Brand Protection
Enterprise Solutions
Printed Solutions
Our Process
Our Investments
Ongoing Disputes
Contact Us
Investor Relations
Press Releases
Corporate Governance
Investor FAQs
Contact IR
Corporate Overview
Financial Tearsheet
Executive Summary
Stock Information
Company News
SEC Filings
Email Alerts
IR & Media Contacts
Executive Team
Board of Directors
Company Presentations
On-Demand Webinars
Videos & Media
Investor FAQs
Corporate By-Laws
SIGN UP FOR IR ALERTS:
Press Releases
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
1
2
3
→
»
Date
Headline
10/01/2020
Impact BioMedical to Begin Efficacy Testing of Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary - Innate Immune, Inc.
09/28/2020
DSS Expands Board with Appointment of Chan Tung Moe
09/22/2020
DSS Reiterates Plans for Impact BioMedical Share Dividend
09/17/2020
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance
09/08/2020
Impact BioMedical Initiates Bioplastics Research Collaboration with One of World’s Largest Plastic Manufacturers
09/01/2020
DSS Announces Multi-Year Contract Valued at $9.6M with One of World’s Largest Photography and Image Sharing Companies
08/31/2020
DSS Announces Record Date for Impact BioMedical Share Dividend
08/26/2020
DSS Interview to Air on Bloomberg International on the RedChip Money Report
08/21/2020
DSS Completes Impact BioMedical Acquisition
08/14/2020
DSS Announces Second Quarter 2020 Financial Results
